| 000 | 01103 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517030040.0 | ||
| 264 | 0 | _c20160204 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1534-3111 | ||
| 024 | 7 |
_a10.1007/s11906-015-0551-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLovshin, J A | |
| 245 | 0 | 0 |
_aAre SGLT2 inhibitors reasonable antihypertensive drugs and renoprotective? _h[electronic resource] |
| 260 |
_bCurrent hypertension reports _cJun 2015 |
||
| 300 |
_a551 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 | _aCytoprotection |
| 650 | 0 | 4 |
_aDiabetes Complications _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 _xmetabolism |
| 650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
| 700 | 1 | _aGilbert, R E | |
| 773 | 0 |
_tCurrent hypertension reports _gvol. 17 _gno. 6 _gp. 551 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11906-015-0551-3 _zAvailable from publisher's website |
| 999 |
_c24823722 _d24823722 |
||